Professor Gesine Hansen is an internationally renowned expert in pediatric pulmonology, allergology and immunology.
Since 2005 she has been the Director of the Children‘s Hospital and Head of the Department of Pediatric Pneumology and Neonatology at the MHH.
Professor Hansen leads a large, internationally renowned research group with the support of various national and international institutions. She is the recipient of many international honors, and was recently awarded the Hansen Prize by the Society of Allergology and Clinical Immunology for her exceptional research in pediatric allergology. She is the president of the International Society of Pediatric Pneumology and active in various other pediatric societies.
The Department of Pediatric Pneumology and Neonatology of the MHH provides state-of-the-art diagnosis and the best possible treatment of all diseases of the lung, immunological disorders, and diseases of the newborn.
The MHH is nationally and internationally known for excellence in the treatment of childhood asthma, cystic fibrosis and rare lung diseases. The MHH is also the largest center for childhood lung transplantation in Europe, offering exceptional expertise in the care of these patients.
Moreover, the MHH has highly specialized clinics for allergic and immunological disorders; its Clinic for Immunological Disorders has been accredited as one of 20 centers of excellence worldwide for primary immunodeficiencies (Jeffrey Modell Center).
The Department of Pediatric Pneumology and Neonatology is a center for:
The clinical team of Professor Hansen‘s Department consists of more than 30 highly experienced pediatricians and over 60 nurses who provide excellent care in all fields of modern pediatric pneumology, allergology, immunology and neonatology.
As one of the leading university hospitals in Germany, the MHH´s technical equipment meets the highest possible standards.
The excellent clinical work of the Department is based on the research of more than 40 dedicated scientists.
Research groups on asthma, allergy and immunological disorders focus on the cause of these diseases, while also continuing to develop innovative diagnostic and treatment strategies.
The cystic fibrosis research group has earned an excellent international reputation for its work on Pseudomonas aeruginosa in recent years. Moreover, this group has developed new methods for the diagnosis of rare lung diseases in children, particularly in infants, and has successfully applied these innovations in clinical practice.